Mechanisms linking obesity to insulin resistance and type 2 diabetes
What Are GLP-1 Medications: Final Takeaways GLP-1 medications mimic the GLP-1 hormone to assist in controlling blood sugars and weight, establishing them as effective treatment options for type 2 diabetes and obesity
The rationale is that weight loss beyond 15% often produces clinically meaningful improvements in joint symptoms, and retatrutide consistently crosses that threshold at moderate doses
Persistent vomiting or diarrhoea can lead to dehydration, which in turn may affect kidney function
Weight gain during this stage is driven by a significant decline in estrogen, which causes the body to redistribute fat specifically toward the abdomen and internal organs as visceral fat
They buy from various sources, sometimes Tier 1 or Tier 2 manufacturers, sometimes from unknown producers, and resell under their own branding